In this free webinar, learn the perspectives on patient-focused research, incorporating the patient as a key stakeholder in relevant aspects of clinical trials from design of protocol, to approaches to trial recruitment and managing patient burden. Attendees will learn industry strategies to address the changing regulatory landscape and requirements for patient-focused drug development. The featured speakers will share insights on different strategies available and how sponsor, CRO, patient support/advocacy groups and other industry players can work together make it easier for patients to become involved and be heard.
TORONTO (PRWEB) June 14, 2022
In this free webinar, learn the perspectives on patient-focused research, incorporating the patient as a key stakeholder in relevant aspects of clinical trials from design of protocol, to approaches to trial recruitment and managing patient burden. Attendees will learn industry strategies to address the changing regulatory landscape and requirements for patient-focused drug development. The featured speakers will share insights on different strategies available and how sponsor, CRO, patient support/advocacy groups and other industry players can work together make it easier for patients to become involved and be heard.
Patient need has always been the reason for drug development. But while industry has long spoken of "patient-centricity" as a key to continued progress, the concept has fallen short — largely due to well-meaning conversations about patients rather than with patients. Only recently has a true "patient voice" become recognized as an essential asset in the development of medicines that matter to patients, a result of sustained patient advocacy and regulatory efforts such as the US Food and Drug Administration (FDA)'s Patient-Focused Drug Development initiative. Patient perspectives can have an invaluable impact on clinical trials.
The need is even more acute for novel and emerging, and particularly oncology and "next-generation" cell therapies in difficult to treat settings, which pose unique challenges for patients and their families.
How can we continue to get closer to meeting and beating the real-world expectations of patients and caregivers, and ensure we stay one step ahead of the heightened expectations of regulators, payers and customers?
Join this webinar to learn more about why engaging patient perspectives is essential to clinical trials.
Join Lynn Donald, Senior Project Director, Novel and Emerging Therapies, Syneos Health; Dr. Rayna Patel, Co-Founder and CEO, Vinehealth; patient speaker, Rebeca James, Senior Project Manager, Syneos Health; and webinar moderator Jane Bentley, Vice President, Oncology Business Strategy, Syneos Health, for the live webinar on Thursday, June 30, 2022, at 9am EDT (2pm BST/UK).
For more information, or to register for this event, visit Next-Gen Cell Therapies: Listening and Engaging with Patient Perspectives as an Essential Element in Clinical Trials.
About Syneos Health
Syneos Health® SYNH is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
For the original version on PRWeb visit: https://www.prweb.com/releases/next_gen_cell_therapies_listening_and_engaging_with_patient_perspectives_as_an_essential_element_in_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb18735525.htm
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
